IBB vs UPRO
iShares Biotechnology ETF vs ProShares UltraPro S&P500
- • IBB has the lower expense ratio at 0.44% vs 0.88% for UPRO.
- • UPRO pays a higher dividend yield (0.80%).
Side-by-side metrics
| Metric | IBB | UPRO |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.88% |
Dividend yield Trailing 12-month yield. | 0.16% | 0.80% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $5.19B |
YTD return | 30.22% | 19.88% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 3.04 |
P/E ratio | 25.48 | 24.27 |
Last price | $217.75 | $142.56 |
Inception | — | — |
Issuer | iShares | ProShares |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
UPRO top holdings
| IQMM | ProShares GENIUS Money Market ETF | 21.67% |
| AAPL | Apple Inc | 3.96% |
| NVDA | NVIDIA Corp | 3.90% |
| MSFT | Microsoft Corp | 3.05% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About UPRO
UPRO (ProShares UltraPro S&P500) is 3x leveraged daily performance of the S&P 500. Managed by ProShares, the fund carries $5.2B in assets under management, an expense ratio of 0.88%, a dividend yield of 0.80%. Its largest holding is ProShares GENIUS Money Market ETF (IQMM), which represents 21.7% of the portfolio. Real Estate is the fund's largest sector exposure at 1.8%.